martes, 6 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 21, 2026

Netflix (NFLX) Q4 2025 Earnings Call Transcript

View original at nasdaq.com
Netflix (NFLX) Q4 2025 Earnings Call Transcript Image source: The Motley Fool. Date Tuesday, Jan. 20, 2026 at 4:45 p.m…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Netflix content cash-to-expense ratio is 1.1x

    80% confidence
  • YouTube surpassed BBC monthly average audience in the UK according to Barb

    80% confidence
  • Netflix will add 2+ live operation centers in 2026 in UK and Asia

    80% confidence
  • Q2 2024 operating margin expanded 5 percentage points year-over-year

    80% confidence
  • Approximately one-third of Netflix members have access to TV-based games through client upgrades

    80% confidence
  • Netflix targets 2026 operating margin of 31.5%, up 2 percentage points including 0.5 point M&A expense headwind

    80% confidence
  • Netflix retention is among the best in the industry

    80% confidence
  • Netflix targets $3 billion in ad revenue for 2026, doubling from 2025

    80% confidence
  • Netflix revenue grew 16% annually in 2025

    80% confidence
  • Netflix primary quality metric reached all-time high in 2025

    80% confidence
  • Q4 2025 churn improved year-over-year

    80% confidence
  • Netflix tested vertical video for approximately 6 months

    80% confidence
  • Live events represent a relatively small portion of total view hours

    80% confidence
  • Modular interactive video ads with dynamic templates completed testing in late 2025 with global rollout in 2026

    80% confidence
  • Customer satisfaction reached all-time high

    80% confidence
  • Netflix executed 200+ live events

    80% confidence
  • Netflix has approximately 7% of addressable consumer and ad spend globally

    80% confidence
  • Sign-up flow optimization generated material revenue wins in Q2 2024

    80% confidence
  • Branded originals viewing grew 9% year-over-year in H2 2025 and 7% in H1 2025, representing approximately 50% of total viewing

    80% confidence
  • Q2 2024 had strong acquisition and healthy retention across all regions

    80% confidence
  • Netflix operating profit grew approximately 30% in 2025

    80% confidence
  • The Warner Bros. deal is pro-consumer, pro-innovation, pro-worker, pro-creator, and pro-growth

    80% confidence
  • Total Netflix view hours grew 2% year-over-year in 2025, adding 1.5 billion hours, accelerating from 1% in prior year

    80% confidence
  • Post-launch party pack games (Boggle, Pictionary, LEGO) achieved approximately 10% reach into eligible members

    80% confidence
  • Ad-supported ARM is currently below ad-free ARM, representing a monetization gap

    80% confidence
  • Netflix 2025 operating margin reached 26%, raised from 25% guidance

    80% confidence
  • 2026 operating margin will be 2.5 points higher excluding M&A expenses

    80% confidence
  • Netflix operates in 12 ad markets

    80% confidence
  • Netflix expects content amortization to increase 10% year-over-year in 2026

    80% confidence
  • Netflix has less than 10% of TV time in all major markets

    80% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com
Netflix (NFLX) Q4 2025 Earnings Call Transcript — Source | Via News | es.VIA.NEWS